Insights from 2023 ESMO Annual Meeting
Playback speed
10 seconds
ESMO 2023 Insights: "Androgen Receptor Pathway Inhibitors or Taxanes for Patients With mCRPC - A Direct Comparison in ProBio, a Randomized, Outcome-Adaptive, Biomarker-Driven Platform Trial"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Henrik Grönberg
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Henrik Grönberg
86 views
October 30, 2023
Comments 0
Login to view comments.
Click here to Login
Genitourinary